A zantac lawsuit lawyer can still help you pursue a cancer claim in 2026, but the legal path has changed dramatically since the federal MDL was dismissed. If you took Zantac and later developed cancer, your window to act is narrowing.
Thousands of cases were thrown out at the federal level in 2022. But state courts across the country have picked up where the federal system left off. Several states are actively moving cases toward trial.
This guide breaks down everything you need to know right now. You’ll learn which courts are hearing cases, what cancers qualify, how much money is at stake, and how to pick the right lawyer. Over 70,000 people originally filed Zantac claims. In 2026, only a fraction still have viable paths forward.
Here’s what those paths look like.
What a Zantac Lawsuit Lawyer Does for Your Case
A zantac lawsuit lawyer represents people who developed cancer after using Zantac or generic ranitidine. These attorneys handle every step of your claim, from gathering medical records to arguing your case in court.
The job goes far beyond paperwork. Your lawyer investigates your history of Zantac use, connects your diagnosis to NDMA exposure, and builds a case showing the drug manufacturer failed to warn you. They also deal with expert witnesses, lab testing, and opposing counsel from billion-dollar pharmaceutical companies.
Think of it like hiring a general contractor for a home renovation. You could try doing it yourself, but the plumbing, electrical, and structural work requires someone who’s done it hundreds of times before. A lawsuit against Sanofi or GlaxoSmithKline works the same way.
| What Your Lawyer Handles | Why It Matters |
|---|---|
| Medical record collection | Proves your cancer diagnosis and Zantac use |
| Expert witness coordination | Scientists testify that NDMA causes cancer |
| Court filings and motions | Meets strict legal deadlines |
| Settlement negotiation | Fights for the highest possible payout |
| Trial preparation | Ready if your case goes before a jury |
Most zantac lawsuit lawyers work on contingency. That means you pay nothing unless you win. There’s no hourly billing and no retainer fee upfront.
The right attorney makes the difference between a dismissed case and a real shot at compensation.
Why You Need a Zantac Lawsuit Attorney in 2026
A zantac lawsuit attorney is more important now than at any point in this litigation’s history. The federal MDL dismissal in December 2022 changed the entire legal playing field, and only experienced attorneys know how to work within what’s left.
Judge Robin Rosenberg excluded plaintiffs’ expert witnesses under the Daubert standard. That ruling effectively killed federal Zantac claims. But it didn’t end the fight. State courts operate under different evidentiary rules, and several have allowed cases to proceed.
Without a zantac lawsuit attorney who understands the post-MDL landscape, you could waste months filing in the wrong jurisdiction. You could miss a statute of limitations deadline. You could lose your only chance at compensation.
Here’s what changed after the federal dismissal:
- State courts in California, Illinois, and Delaware became the primary battleground
- Each state applies its own rules for expert testimony
- Some states use the Frye standard, which is more favorable to plaintiffs
- New scientific evidence about NDMA has emerged since 2022
A seasoned attorney tracks all of this daily. They know which state gives your case the best odds. They’ve already built relationships with the expert witnesses who can testify on your behalf.
Going into 2026, the cases that survive will be the ones with sharp legal teams behind them.
Zantac Lawsuit Update 2026: Where Things Stand Now
The Zantac lawsuit in 2026 is centered in state courts after the federal MDL was dismissed in late 2022. Several states have active dockets, and bellwether trials could produce the first major verdicts this year.
The federal multidistrict litigation, known as MDL 2924, consolidated over 70,000 cases in the Southern District of Florida. When Judge Rosenberg excluded the plaintiffs’ causation experts, it gutted the federal cases. Most were dismissed without prejudice, meaning they could be refiled elsewhere.
Since then, the action has shifted. Here’s the current status:
| Jurisdiction | Status in 2026 |
|---|---|
| Federal MDL (Florida) | Dismissed, effectively closed |
| California state courts | Active, cases proceeding |
| Illinois state courts | Active, new filings accepted |
| Delaware state courts | Active, trials expected |
| Pennsylvania state courts | Limited activity |
| New Jersey state courts | Cases pending |
New scientific studies published in 2024 and 2025 have strengthened the connection between ranitidine and NDMA formation. Some of these studies address the exact weaknesses Judge Rosenberg identified in the federal proceedings.
State court judges are evaluating this updated evidence independently. They aren’t bound by the federal ruling. That’s why 2026 could be a turning point for Zantac plaintiffs.
Key Takeaway: The federal Zantac MDL is dead, but state courts are very much alive, and 2026 may bring the first trial verdicts that set the tone for future settlements.
Is the Zantac Lawsuit Still Active in 2026?
Yes, the Zantac lawsuit is still active in 2026 through state court proceedings in multiple jurisdictions. The federal case ended, but the litigation itself did not.
This is one of the biggest misconceptions out there. People hear “dismissed” and assume the entire Zantac legal fight is over. That’s not accurate. The federal consolidation was one path. State courts are separate systems with their own rules, judges, and timelines.
California alone has hundreds of pending Zantac cases. Illinois courts have accepted new filings from plaintiffs with strong medical evidence. Delaware’s courts have been particularly receptive.
What makes state courts different:
- Different evidence rules: Many states use the Frye standard, not Daubert
- Independent judges: They make their own rulings on expert testimony
- Jury pools: State juries can be more sympathetic to cancer victims
- No federal precedent binding: The MDL dismissal has no legal authority in state courts
The manufacturers, including Sanofi, Boehringer Ingelheim, GlaxoSmithKline, and Pfizer, are still defending these state court cases. They haven’t walked away. That tells you something about how seriously they take the remaining litigation.
If you used Zantac and were diagnosed with cancer, your case may still be viable. But you need to move quickly. Statutes of limitations don’t wait.
Zantac Lawsuit Eligibility: Do You Qualify?
You may qualify for a Zantac lawsuit if you took Zantac or generic ranitidine regularly and were later diagnosed with certain types of cancer. Both prescription and over-the-counter users are included.
Eligibility isn’t based on just one factor. Lawyers and courts look at a combination of your usage history, cancer diagnosis, and timing. The stronger the connection between your Zantac use and your cancer, the stronger your case.
Here’s a breakdown of the typical eligibility criteria:
| Requirement | Details |
|---|---|
| Zantac or ranitidine use | Must have used the drug for at least several months |
| Cancer diagnosis | Must be a cancer type linked to NDMA exposure |
| Timing | Cancer diagnosis typically after sustained use |
| No other obvious cause | Stronger cases where no family history or other risk factors exist |
| Proof of purchase | Pharmacy records, prescriptions, or personal testimony |
You don’t need a receipt from every purchase. Prescription records, insurance claims, and even doctor’s notes confirming Zantac use can serve as evidence.
People who used Zantac for chronic heartburn or acid reflux over months or years tend to have the strongest claims. Short-term, one-time users face a harder battle proving causation.
Your age, location, and the specific manufacturer of your ranitidine product may also affect where and how your case is filed.
What Cancers Qualify for a Zantac Lawsuit?
The cancers most commonly linked to Zantac lawsuits include bladder, stomach, liver, esophageal, and pancreatic cancers. These are the types most strongly associated with NDMA exposure.
NDMA is classified as a probable human carcinogen by the EPA and the International Agency for Research on Cancer. It damages DNA and has been shown to cause tumors in laboratory studies, particularly in the digestive and urinary systems.
Here are the cancer types that typically qualify:
- Bladder cancer (most commonly filed claim)
- Stomach cancer (gastric cancer)
- Liver cancer (hepatocellular carcinoma)
- Esophageal cancer
- Pancreatic cancer
- Kidney cancer
- Colorectal cancer
- Prostate cancer
- Breast cancer (in some filings)
- Small intestine cancer
Not every cancer type carries the same weight in court. Bladder and stomach cancers have the strongest scientific backing. Cases involving these diagnoses tend to be prioritized by attorneys because the medical literature connecting NDMA to these cancers is most robust.
If your cancer type isn’t on this list, that doesn’t automatically disqualify you. New research continues to emerge. A good lawyer will evaluate whether current science supports your specific claim.
Key Takeaway: Bladder, stomach, and liver cancers are the strongest Zantac claim types, but several other cancers linked to NDMA exposure also qualify for legal action.
Zantac Settlement Amounts: What to Expect in 2026
No official Zantac settlements have been paid as of early 2026. However, legal analysts estimate individual payouts could range from $50,000 to over $500,000 depending on case strength and cancer severity.
Unlike some mass tort cases where global settlements are announced early, Zantac litigation hasn’t reached that stage. The federal MDL dismissal prevented a consolidated settlement. Now, any settlements will likely come through state court verdicts or individual negotiations.
| Case Strength | Estimated Settlement Range |
|---|---|
| Strong (bladder/stomach cancer, long use, strong evidence) | $200,000 to $500,000+ |
| Moderate (other qualifying cancer, moderate use) | $75,000 to $200,000 |
| Weaker (shorter use, less common cancer type) | $50,000 to $100,000 |
These numbers are projections based on similar pharmaceutical lawsuits. The actual amounts will depend on several factors:
- Your specific cancer diagnosis
- How long you used Zantac
- Whether you have pharmacy records or prescriptions
- The state where your case is filed
- Whether the case goes to trial or settles
A single large jury verdict in state court could force manufacturers to negotiate. That’s how it worked in the Roundup litigation. One big win at trial opened the floodgates.
For Zantac plaintiffs, that first verdict could come in 2026 or 2027.
Zantac Lawsuit Payout: When Will Money Arrive?
Zantac lawsuit payouts are not expected to begin until a major state court verdict or settlement agreement is reached, likely in late 2026 at the earliest. Most payments will probably flow in 2027 or beyond.
The timeline for receiving money in mass tort cases is almost always longer than people expect. Even after a verdict, there are appeals, settlement negotiations, and distribution processes that add months or years.
Here’s a realistic payout timeline:
| Milestone | Expected Timeframe |
|---|---|
| State court bellwether trials | 2026 |
| First potential verdicts | Late 2026 to early 2027 |
| Settlement negotiations (if verdicts favor plaintiffs) | 2027 |
| Individual payout distribution | 2027 to 2028 |
Some state courts may reach settlements faster if manufacturers decide the cost of trials exceeds the cost of settling. But pharmaceutical companies like Sanofi have deep legal war chests and a history of fighting hard.
The best thing you can do right now is file your claim and get in line. Cases that are filed and documented early tend to settle faster when money starts flowing.
If anyone promises you a quick payout in 30 or 60 days, that’s a red flag. This is complex pharmaceutical litigation, not a car accident claim.
How to File a Zantac Lawsuit in 2026
Filing a Zantac lawsuit in 2026 starts with contacting a qualified attorney who handles pharmaceutical litigation. You don’t file the paperwork yourself. Your lawyer does everything.
The process is simpler than most people think, especially at the beginning. Here are the steps:
Step 1: Free Case Evaluation
Contact a law firm that handles Zantac cases. Share your Zantac usage history and cancer diagnosis. This initial review costs nothing.
Step 2: Medical Record Collection
Your attorney gathers your medical records, pharmacy history, and insurance claims. They need documentation of both your Zantac use and your cancer diagnosis.
Step 3: Case Filing
Your lawyer files the complaint in the appropriate state court. They choose the jurisdiction that gives your case the best chance based on the evidence rules and judicial history.
Step 4: Discovery and Expert Review
Both sides exchange evidence. Your attorney works with oncologists and toxicologists to establish the connection between NDMA and your cancer.
Step 5: Settlement or Trial
Most mass tort cases settle before trial. But if the manufacturer won’t offer fair compensation, your case goes before a jury.
You don’t pay anything upfront. You don’t travel to court. You don’t deal with the other side’s lawyers. Your attorney handles all of it.
The biggest mistake people make is waiting. Every month you delay brings you closer to a potential statute of limitations deadline.
Key Takeaway: Filing a Zantac lawsuit is free to start, handled entirely by your attorney, and the most important step is simply picking up the phone before deadlines expire.
Zantac State Court Lawsuits: Where Cases Are Moving Forward
Zantac state court lawsuits are active in California, Illinois, Delaware, and several other states where judges have allowed cases to proceed under state evidence standards. These courts are now the primary venue for Zantac claims.
After the federal MDL collapse, plaintiffs’ attorneys regrouped and refiled cases at the state level. This strategy works because state courts aren’t bound by Judge Rosenberg’s Daubert ruling. Each state applies its own test for scientific evidence.
| State | Evidence Standard | Case Status | Notes |
|---|---|---|---|
| California | Frye/Kelly | Active, trials pending | Large number of filings |
| Illinois | Frye | Active, accepting cases | Favorable to plaintiffs |
| Delaware | Liberal admissibility | Active, progressing | Positive rulings on experts |
| New Jersey | Varies by court | Cases pending | Some activity |
| Pennsylvania | Frye | Limited filings | Selective acceptance |
| Maryland | Frye | Some activity | Fewer cases |
The Frye standard is generally easier for plaintiffs to meet than Daubert. Under Frye, expert testimony just needs to be based on methods “generally accepted” in the scientific community. Under Daubert, judges act as gatekeepers and can exclude testimony they find unreliable.
That’s why states using Frye are seeing the most Zantac activity. Plaintiffs’ experts who were excluded in federal court may be allowed to testify in these state proceedings.
If you’re considering filing, your attorney will recommend the best state court based on where you live, where you bought Zantac, and where the evidence rules favor your claim.
Zantac Lawsuit Statute of Limitations: Don’t Miss Your Deadline
The statute of limitations for Zantac lawsuits varies by state, typically ranging from one to six years from the date of cancer diagnosis or the date you discovered the connection to Zantac. Missing this deadline means your case is permanently barred.
This is the single biggest threat to your claim. It doesn’t matter how strong your evidence is or how aggressive your cancer was. If you file one day late, the court will dismiss your case.
| State | Statute of Limitations (Personal Injury) |
|---|---|
| California | 2 years from discovery |
| Illinois | 2 years from discovery |
| Delaware | 2 years from injury |
| New Jersey | 2 years from discovery |
| New York | 3 years |
| Texas | 2 years |
| Florida | 4 years (recently changed) |
| Pennsylvania | 2 years |
The “discovery rule” is important here. In many states, the clock doesn’t start when you first used Zantac. It starts when you were diagnosed with cancer or when you reasonably should have known that Zantac caused your condition.
Since the FDA recalled ranitidine in April 2020 and major media coverage followed, many courts consider 2020 as the point when consumers were put on notice. That means some deadlines may have already passed.
If you haven’t filed yet, contact a lawyer this week. Not next month. Not after the holidays. This week.
The Zantac NDMA Lawsuit: Understanding the Science
The Zantac NDMA lawsuit centers on the discovery that ranitidine, Zantac’s active ingredient, breaks down into NDMA, a cancer-causing chemical, especially when stored at higher temperatures. This contamination was not disclosed to consumers.
In 2019, the online pharmacy Valisure made a stunning discovery during routine testing. They found that Zantac tablets contained extremely high levels of NDMA. Some samples showed NDMA levels thousands of times above the FDA’s acceptable daily limit of 96 nanograms.
The problem wasn’t just contamination during manufacturing. The ranitidine molecule itself is inherently unstable. When exposed to heat, even normal body temperature, it can convert into NDMA inside the human body.
Key scientific facts:
- NDMA stands for N-Nitrosodimethylamine
- It’s classified as a probable human carcinogen by the WHO and EPA
- Ranitidine can produce NDMA levels exceeding 3,000,000 nanograms per tablet under certain conditions
- The FDA’s acceptable limit is just 96 nanograms per day
- Body temperature alone can trigger NDMA formation from ranitidine
This means every time someone took a Zantac pill, they may have been ingesting a potent carcinogen. Manufacturers allegedly knew about ranitidine’s instability for decades but failed to warn consumers or doctors.
The science is the backbone of every Zantac case. Your lawyer’s ability to present this evidence effectively determines whether your claim succeeds.
Key Takeaway: Ranitidine doesn’t just contain NDMA as a contaminant; the molecule itself breaks down into this carcinogen, which is why the entire product was pulled from the market.
Zantac Class Action Lawsuit vs. Individual Claims
The Zantac lawsuit is not technically a class action. It’s a mass tort, which means each person files their own individual claim with their own specific damages, rather than being part of one collective case.
People use the term “class action” loosely, but the distinction matters for your wallet. In a true class action, everyone gets the same payout. In a mass tort, your compensation is based on your specific injuries, medical costs, and suffering.
| Feature | Class Action | Mass Tort (Zantac) |
|---|---|---|
| Individual assessment | No | Yes |
| Payout amount | Same for all members | Varies per person |
| Your own lawyer | Usually not | Yes |
| Control over your case | Minimal | More control |
| Settlement speed | Often faster | Can take longer |
| Compensation potential | Usually lower | Usually higher |
Mass tort cases tend to pay significantly more per plaintiff than class actions. That’s because your attorney presents evidence specific to your cancer, your suffering, and your financial losses.
The tradeoff is time. Individual assessment means each case gets evaluated separately. That process takes longer than a blanket class action settlement.
For Zantac plaintiffs, the mass tort structure is actually an advantage. Someone with stage 4 bladder cancer and $300,000 in medical bills should receive far more than someone with a less severe diagnosis. The mass tort framework allows that.
How to Choose the Best Zantac Lawsuit Lawyer
The best zantac lawsuit lawyer has specific experience with pharmaceutical mass torts, a track record in Zantac litigation, and the resources to fund your case through trial if necessary. Not every personal injury attorney qualifies.
Picking the wrong lawyer is like hiring a plumber to rewire your house. They might be a great professional in their field, but this job requires different expertise.
Here’s what to look for:
- Zantac case experience: Have they handled Zantac claims before?
- Mass tort track record: How many pharmaceutical cases have they won or settled?
- Trial willingness: Will they actually go to trial, or do they only settle?
- Financial resources: Can they fund expert witnesses, lab tests, and years of litigation?
- Communication style: Do they return calls? Do they explain things clearly?
Red flags to avoid:
- Promises of guaranteed payouts. No honest lawyer guarantees money.
- Pressure to sign immediately. Good firms give you time to decide.
- No specific Zantac experience. General personal injury lawyers may lack the specialized knowledge.
- Charging upfront fees. Legitimate Zantac attorneys work on contingency.
- Mass advertising with no substance. TV ads don’t equal courtroom skill.
Ask potential lawyers these questions during your consultation:
- How many Zantac cases have you filed?
- In which state courts are your cases pending?
- What’s your assessment of my case’s strength?
- How long do you expect my case to take?
- What percentage do you take from any settlement?
The answers will tell you everything you need to know.
Zantac Lawyer Fees: What You’ll Actually Pay
Zantac lawyer fees are based on contingency, meaning you pay nothing unless your case wins or settles. The standard contingency rate for pharmaceutical lawsuits is 33% to 40% of the total recovery.
This fee structure exists because most cancer patients can’t afford to pay a lawyer $500 per hour to fight Sanofi for three years. Contingency makes justice accessible.
| Fee Type | Amount | When You Pay |
|---|---|---|
| Upfront retainer | $0 | Never |
| Hourly billing | $0 | Never |
| Contingency fee | 33% to 40% of your payout | Only if you win |
| Case expenses (costs) | Varies | Deducted from settlement or waived |
Some firms deduct case expenses, like expert witness fees and court filing costs, from your settlement. Others absorb those costs entirely. Ask about this before signing.
Let’s put this in real numbers. If your case settles for $200,000 and your lawyer takes 35%, you’d receive $130,000. The lawyer gets $70,000. Any case expenses would come out of either your share or theirs, depending on the agreement.
That might sound like a lot, but consider what you get. Years of legal work. Expert witnesses who charge $500 per hour. Court filings in multiple states. All funded by the firm, not by you.
If any attorney asks for money upfront to handle your Zantac case, walk away. That’s not how this works.
Key Takeaway: You never pay a dime out of pocket for a Zantac lawsuit. Your lawyer only gets paid when you get paid, and the standard cut is 33% to 40%.
Zantac Lawsuit Evidence Requirements: Building a Strong Case
Strong Zantac lawsuit evidence includes documented proof of ranitidine use, a qualifying cancer diagnosis, medical records showing treatment history, and expert testimony linking NDMA exposure to your specific cancer.
Evidence wins cases. Without it, even the most sympathetic cancer story won’t survive in court. Your attorney needs to build a chain connecting three things: your Zantac use, the NDMA in Zantac, and your cancer.
Types of evidence your lawyer will gather:
- Pharmacy records showing Zantac or ranitidine purchases
- Prescription history from your doctor or insurance company
- Medical records documenting your cancer diagnosis and treatment
- Pathology reports identifying the type and stage of cancer
- Expert testimony from toxicologists and oncologists
- Personal testimony about how long and how often you used Zantac
What if you don’t have pharmacy receipts from years ago? That’s more common than you’d think. Your lawyer can subpoena pharmacy databases, pull insurance claims, and request prescription records from your healthcare providers.
Some people kept the actual Zantac bottles. That’s rare, but if you have one, it’s valuable. Lab testing can determine the NDMA level in your specific product.
The evidence bar is higher now than before the federal MDL dismissal. State court judges are watching closely. Your lawyer needs rock-solid documentation and credible expert witnesses.
Don’t assume your evidence is too weak before talking to an attorney. Let them evaluate it. You might have more proof than you realize.
Zantac Lawsuit Timeline: Key Dates and Milestones
The Zantac lawsuit timeline spans from 2019, when NDMA was first discovered in ranitidine, through 2026, when state court trials may produce the first verdicts. Here’s a chronological breakdown of every major milestone.
| Date | Event |
|---|---|
| September 2019 | Valisure discovers high NDMA levels in Zantac |
| September 2019 | FDA begins investigating ranitidine products |
| April 2020 | FDA requests all ranitidine products be withdrawn from market |
| February 2020 | MDL 2924 created in Southern District of Florida |
| 2020 to 2022 | Over 70,000 cases consolidated in federal MDL |
| December 2022 | Judge Rosenberg excludes plaintiffs’ experts under Daubert |
| December 2022 to January 2023 | Federal cases dismissed |
| 2023 to 2024 | Plaintiffs refile in state courts across the country |
| 2024 to 2025 | New scientific studies published strengthening NDMA-cancer link |
| 2025 | State courts schedule bellwether trials |
| 2026 | First state court trials expected |
| Late 2026 to 2027 | Potential verdicts and settlement negotiations |
The Zantac litigation has been a marathon, not a sprint. Plaintiffs who filed in 2020 have waited over five years without seeing a dollar. That’s frustrating, but it’s the reality of pharmaceutical lawsuits.
The good news is that the timeline is reaching its most consequential phase. State court trials could produce the precedent-setting verdicts that force manufacturers to settle.
If you haven’t filed yet, you’re not too late, but you’re close to some statute of limitations deadlines. Acting in 2026 is still possible. Waiting until 2027 might not be.
Key Takeaway: The Zantac lawsuit is entering its most critical phase in 2026, with state court trials that could finally force manufacturers to pay.
Finding a Ranitidine Lawsuit Attorney Near You
A ranitidine lawsuit attorney handles the same cases as a Zantac lawsuit lawyer; ranitidine is simply the generic name for the drug sold under the Zantac brand. Both brand-name and generic users have legal claims.
Many people don’t realize they took ranitidine because they bought a store-brand version. CVS, Walgreens, Walmart, Costco, and dozens of other retailers sold their own ranitidine products. All of these products contained the same unstable molecule that produces NDMA.
Manufacturers of generic ranitidine include:
- Apotex
- Dr. Reddy’s Laboratories
- Amneal Pharmaceuticals
- Aurobindo Pharma
- Sandoz
- Lannett Company
If you used any of these generic products, you have the same legal standing as someone who used brand-name Zantac.
Finding an attorney near you isn’t always necessary. Most Zantac and ranitidine lawyers work with clients nationwide. Your case will be filed in whichever state court offers the best strategic advantage, not necessarily your home state.
During your search, look for attorneys who specifically mention ranitidine and generic Zantac on their practice pages. Some firms only focus on claims against Sanofi, the brand-name manufacturer. You want a firm that also targets generic manufacturers, since they share liability.
A free case evaluation takes about 15 to 30 minutes. You’ll discuss your usage, diagnosis, and medical history. The attorney will tell you whether you have a viable claim and explain the next steps.
Frequently Asked Questions
Can I still file a Zantac lawsuit in 2026?
Yes, you can still file in several state courts in 2026.
Your eligibility depends on your state’s statute of limitations and your cancer diagnosis date.
Contact an attorney immediately to confirm your deadline hasn’t passed.
How much money can I get from a Zantac lawsuit?
Estimated individual payouts range from $50,000 to $500,000 or more.
The amount depends on your cancer type, treatment costs, and strength of evidence.
No official settlements have been finalized yet.
What cancers qualify for a Zantac claim?
Bladder, stomach, liver, esophageal, pancreatic, kidney, and colorectal cancers are the most commonly accepted types.
Bladder and stomach cancers have the strongest scientific support.
Other cancer types may qualify as new research develops.
How much does a Zantac lawsuit lawyer charge?
Most charge a contingency fee of 33% to 40% of your settlement.
You pay nothing upfront and nothing if your case doesn’t win.
Case expenses may be deducted from your recovery or absorbed by the firm.
How long does a Zantac lawsuit take to settle?
Most cases will take one to three years from filing to resolution.
The first state court verdicts are expected in late 2026 or early 2027.
Settlements typically follow major trial outcomes.
The Zantac lawsuit has reached a turning point in 2026. State courts are moving cases forward, and the first trial verdicts could reshape everything.
If you used Zantac or generic ranitidine and developed cancer, now is the time to act. Check your eligibility, gather your medical records, and talk to an experienced attorney before your statute of limitations runs out.
Your case won’t file itself. But the right lawyer will make sure it gets filed right.
